FS
[UGFS]
and
endovenous

thermal ablation).91 Although the cost effectiveness was
calculated for the UK, sensitivity analysis suggests that
the conclusions are robust to substantial changes in relative cost, and pertinent to other global healthcare
markets.
As an example, the REACTIV Trial, in which a subgroup
of patients with severe varicosities were randomized to
surgical therapy (HL&S, phlebectomy) compared with
compression therapy.9